Free Trial
NASDAQ:IMAC

IMAC (IMAC) Stock Price, News & Analysis

IMAC logo
$0.04 +0.00 (+8.11%)
As of 04/25/2025

About IMAC Stock (NASDAQ:IMAC)

Key Stats

Today's Range
$0.04
$0.04
50-Day Range
$0.04
$0.66
52-Week Range
$0.75
$1.65
Volume
666 shs
Average Volume
708,132 shs
Market Capitalization
$1.06 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

IMAC Holdings, Inc. owns, manages, and subleases a chain of innovative medical advancements and care regeneration centers in the United States. The company's outpatient medical clinics provide regenerative, orthopedic, and minimally invasive procedures and therapies to patients with sports injuries, ligament and tendon damage, and other related soft tissue conditions, as well as back, knee, and joint pains. It also provides physical therapy and spinal decompression, and chiropractic manipulation. The company owns or manages 15 outpatient medical clinics in Kentucky, Missouri, Tennessee, Illinois, Louisiana, and Florida. IMAC Holdings, Inc. was founded in 2000 and is headquartered in Brentwood, Tennessee.

Receive IMAC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IMAC and its competitors with MarketBeat's FREE daily newsletter.

IMAC Stock News Headlines

Donald Trump is about to free crypto from its chains …
Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election … surpassing $100,000 on Dec. 8 .… Now Juan believes it could hit $150,000 … or higher in 2025.
How to Quickly Set Up Your New Mac
Why The New iMac Has White Bezels
See More Headlines

IMAC Stock Analysis - Frequently Asked Questions

IMAC's stock was trading at $1.27 on January 1st, 2025. Since then, IMAC stock has decreased by 96.9% and is now trading at $0.04.
View the best growth stocks for 2025 here
.

IMAC Holdings, Inc. (NASDAQ:IMAC) released its quarterly earnings results on Thursday, April, 14th. The company reported ($0.11) earnings per share for the quarter, missing analysts' consensus estimates of ($0.09) by $0.03. IMAC had a negative net margin of 75.40% and a negative trailing twelve-month return on equity of 52.17%.

IMAC (IMAC) raised $4 million in an initial public offering on the week of February 11th 2019. The company issued 900,000 shares at $5.00 per share. Dawson James Securities and Cuttone served as the underwriters for the IPO.

Shares of IMAC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that IMAC investors own include Advanced Micro Devices (AMD), Nokia Oyj (NOK), iBio (IBIO), VBI Vaccines (VBIV), Avino Silver & Gold Mines (ASM), Avino Silver & Gold Mines (ASM) and Energy Transfer (ET).

Company Calendar

Last Earnings
4/14/2022
Today
5/01/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Specialty Outpatient Clinics
Sub-Industry
N/A
Current Symbol
NASDAQ:IMAC
Fax
N/A
Employees
106
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-10,540,000.00
Pretax Margin
-75.40%

Debt

Sales & Book Value

Annual Sales
$15.22 million
Price / Cash Flow
N/A
Book Value
$0.69 per share
Price / Book
0.06

Miscellaneous

Free Float
23,837,000
Market Cap
$1.06 million
Optionable
Not Optionable
Beta
-0.88
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (NASDAQ:IMAC) was last updated on 5/1/2025 by MarketBeat.com Staff
From Our Partners